Clinical Studies

The project is focused on blood and tissue sample collection to evaluate circulating tumor cells in the blood of dogs with suspected osteosarcoma or hemangiosarcoma. Dogs who qualify will have a single blood sample collected prior to surgery and a tissue sample collected at the time of surgery.

The goal of this study is to evaluate changes in procalcitonin levels over time in canine patients surgically treated for sepsis secondary to an abdominal cause (i.e. ruptured intestine). Additional blood sample collection will also be performed to investigate for possible novel markers for sepsis using next generation sequencing for the future development of diagnostic test.

Ethos Discovery now seeks to deliver a highly advanced clinical trial program investigating the use of novel drugs for the treatment of Hemangiosarcoma (HSA) with the goal of curing this aggressive cancer. This study will ask if drugs specifically matched to the genomic subtypes of patients with HSA will result in improved outcomes.